Detalles de la búsqueda
1.
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Br J Cancer;
130(8): 1269-1278, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402342
2.
Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme.
Scand J Rheumatol;
48(5): 345-352, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31210083
3.
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis.
Pharmacogenomics J;
17(6): 535-542, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27897268
4.
Real-life treatment of metastatic colorectal cancer with regorafenib: a single-centre review.
Curr Oncol;
24(4): 234-239, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28874891
5.
Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer.
Curr Oncol;
24(4): e261-e268, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28874896
6.
Tissue Factor Pathway Inhibitor Gene Polymorphism -33T â C Predicts Improved Disease-Free Survival in Colorectal Cancer.
Ann Surg Oncol;
23(7): 2274-80, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26968713
7.
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.
Pancreatology;
16(6): 1106-1112, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27600995
8.
Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.
Dis Esophagus;
29(8): 1152-1158, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26663741
9.
Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guideline.
Curr Oncol;
23(6): 418-424, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28050138
10.
Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancers.
Curr Oncol;
23(1): 52-5, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26966404
11.
A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium.
Br J Cancer;
113(11): 1534-40, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26554651
12.
A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients.
Pharmacogenomics J;
15(6): 513-20, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25778466
13.
A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors.
Invest New Drugs;
33(2): 321-31, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25380635
14.
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer.
Br J Cancer;
110(3): 648-55, 2014 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24335920
15.
Use of chemotherapy and radiofrequency ablation to treat colorectal cancer metastases: a retrospective review of The Ottawa Hospital Cancer Centre over 7 years.
Curr Oncol;
21(4): e557-63, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25089107
16.
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17.
Ann Oncol;
24(4): 953-60, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23144444
17.
NCIC CTG IND.181: phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignancies.
Invest New Drugs;
31(6): 1522-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24072436
18.
Rationalisation in public dental care--impact on clinical work tasks and mechanical exposure for dentists--a prospective study.
Ergonomics;
56(2): 303-13, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23419089
19.
Working conditions, health and productivity among dentists in Swedish public dental care--a prospective study during a 5-year period of rationalisation.
Ergonomics;
56(9): 1376-86, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23862657
20.
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care.
Ann Oncol;
22(1): 118-126, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20603436